Radiology Solutions
AI-powered solutions to accelerate radiology diagnosis and treatment
Software · Cloud SaaSCompany source
Company profile
About Viz.ai
Viz.ai uses artificial intelligence to accelerate care coordination, reducing the time between diagnosis and treatment for patients with life-threatening conditions.
Company description Viz.ai official website
Primary marketMedical Imaging & Radiology
Commercial modelCommercial information available on request
Work at Viz.ai?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
- Abdominal Aortic Aneurysm (AAA)
- Acute Coronary Syndrome (ACS)
- Aortic Disease
- Cardiac Amyloidosis
- Cerebral Aneurysm
- Hemorrhage
- Hypertrophic Cardiomyopathy
- Large Vessel Occlusion (LVO)
- Oncology conditions
- Osteoporosis
- Pulmonary Embolism
- Respiratory conditions
- Stroke
- Subdural Hemorrhage
- Trauma
Who it serves
- Health Systems
- Hospitals
- Medical Device Companies
- Pharma
- Regional Networks
- Rural Hospitals
- Trauma Centers
Deployment & integration
Cloud Saas deployment with recorded integration context.
Geographic context
MarketsEuropean Union · United States
Company sourceOfficial website
Company milestones
Platform expansion
Launched Viz Pulmonary Suite as first comprehensive AI-powered solution dedicated to pulmonary care delivery. Achieved $1 billion valuation (mentioned in Forbes Next Billion-Dollar Startups 2021). Expanded to 50+ FDA-cleared algorithms.
Partnerships
Recorded partners
- Cooper University Health Care
- Medical device companies
- Microsoft Cloud for Healthcare
- Pharmaceutical companies
- Piedmont Healthcare
- Swedish Medical Center Denver
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
Vascular Solutions
AI-powered solutions for vascular medicine patient outcomes
Software · Cloud SaaSCompany source
Viz Assist
AI-powered workflow assistant for care coordination
Software · Cloud SaaSCompany source
Viz Cardio Suite
AI-powered cardiovascular disease detection and care coordination
Software · Cloud SaaSCompany source
Viz Life Sciences
Customized AI solutions for pharmaceutical and medical device companies
Platform · Cloud SaaSCompany source
Viz Neuro Suite
AI-powered suite for detecting and treating neurovascular diseases
Software · Cloud SaaSCompany source
Viz Oncology Suite
AI-powered oncology care coordination solution
Software · Cloud SaaSCompany source
Viz Pulmonary Suite
First comprehensive AI-powered solution for pulmonary care delivery
Software · Cloud SaaSCompany source
Viz Trauma Suite
AI-powered trauma center communication and patient response solution
Software · Cloud SaaSCompany source
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
Artificial Intelligence for the Detection of Hypertrophic Cardiomyopathy From Standard Electrocardiogram.JACC. Advances · Jun 16, 2026
The implementation of an artificial intelligence-based software for large vessel occlusion stroke improves door-to-puncture time at a comprehensive stroke center.Internal and emergency medicine · Nov 20, 2025
Clinical implementation of an AI-enabled ECG for hypertrophic cardiomyopathy detection.Heart (British Cardiac Society) · Oct 14, 2025
Estimation of Ventricular and Intracranial Hemorrhage Volumes and Midline Shift on an External Validation Data Set Using a Convolutional Neural Network Algorithm.Neurosurgery · Apr 14, 2025
Should they stay or should they go? Stroke transfers across a hospital network pre- and post-implementation of an automated image interpretation and communication platform.Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences · Aug 14, 2024
Including isolated aphasia improves sensitivity and negative predicative value for large vessel occlusion screening.Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association · Aug 1, 2024
Clinical validation
Clinical-trial records
No linked records are currently available.
Regulatory
Regulatory records
Viz Subdural+, Viz SUBDURAL PLUSK250354 · 510k · Jun 10, 2025
Viz HDS, Viz Volume Plus, Viz ICH+K232363 · 510k · Feb 5, 2024
Viz HCMDEN230003 · De Novo · Aug 3, 2023
Viz AAAK223443 · 510k · Mar 17, 2023
Viz LVO ContaCTK223042 · 510k · Oct 21, 2022
Viz RV/LVK221100 · 510k · Aug 29, 2022
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
Time savings
Significantly save time and improve patient and economic outcomes
Accelerated diagnosis
Auto-detect suspected diseases in seconds
Faster treatment decisions
Accelerate time to diagnosis and treatment
Cooper University Health Care
Utilizing AI for patient care transformation and identifying individuals with AAA for automatic referral
Piedmont Healthcare
Expedited implementation and ongoing support for neurology care coordination
Swedish Medical Center, Denver
Stroke care coordination with LVO detection alerts enabling quick mobile review
New standard for stroke care established
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
No active leadership profiles are currently listed.
06 · Company updates
Updates from Viz.ai
Recent articles published on Viz.ai's official website.
Fast, Predictable, Simple: Lessons from Viz.ai’s Imaging Architecture
Read on Viz.aiConnecting Rural Hospitals to their Regional Network
Read on Viz.aiThe ROI Never Expected: When a PE Alert Became Personal
Read on Viz.aiThe Answer to the US Healthcare Crisis? AI Care Pathways
Read on Viz.aiPhysicians Are Ready for AI…and Health Systems Need a Better Path Forward
Read on Viz.ai07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Medical Imaging & Radiology
Companies that apply AI to analyze medical images for diagnostic purposes, workflow optimization, or clinical decision support. Covers general radiology (X-rays, CT scans, MRIs, ultrasounds) across multiple organ systems, as well as specialized imaging in ophthalmology and dermatology.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market
10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.